English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
Nicholas Gueguen
| Jun 30, 2017
Shire study sees reduction in hereditary angioedema episodes using lanadelumab
Ruth de Jauregui
| May 3, 2017
Study indicates one bleeding incident every 3-15 seconds among hemophiliacs
Robert Hadley
| Apr 28, 2017
Shire’s hashtag campaign focusing on primary immunodeficiency
Keri Carbaugh
| Feb 6, 2017
Shire takes lead on rare conditions, CEO says
Keri Carbaugh
| Jan 18, 2017
Shire again offers scholarship for students with ADHD
Amanda Rupp
| Jun 11, 2016
Shire shareholders approve Baxalta merger
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Apr 17, 2016
Shire sends application to FDA for chewable Vyvanse tablets
Trending
+
Pharmaceuticals
Patient Daily
| Jun 2, 2025
PathAI collaborates with Northwestern Medicine on digital pathology advancements
+
Regulatory
Patient Daily
| May 30, 2025
Alliance for Pharmacy Compounding calls for eliminating redundant, unauthorized, or ineffective regulation
+
Pharmaceuticals
Patient Daily
| May 29, 2025
Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+
Pharmaceuticals
Patient Daily
| Jun 5, 2025
Exon 20 Group questions effectiveness of 340B drug program
